It has been proven that following demyelination, Oligodendrocyte Progenitor Cells (OPCs) migrate to the lesion website and start to proliferate, and differentiate. This examine aimed to analyze the results of Hydroxychloroquine (HCQ) on the expression of OLIG-2 and PDGFR-α markers in the course of the myelination course of.
C57BL/6 mice had been fed cuprizone pellets for five weeks to induce demyelination and return to a standard weight-reduction plan for 1 week to stimulate remyelination. In the course of the Part I all the animals besides CPZ and Automobile teams had been uncovered to HCQ (2.5, 10, and 100 mg/kg) by way of consuming water.
On the finish of the examine, animals had been euthanized, perfused and the mind samples had been assessed for myelination and immunohistochemistry analysis. What’s exceptional is the excessive fee of Olig2 + cells within the teams handled with 10 and 100 mg/kg HCQ within the demyelination section and its lowering pattern within the remyelination section.
Nevertheless, there was no important distinction between teams throughout section I and Part II based mostly on the share of olig-2+/whole cells within the corpus callosum area. The variety of PDGFR-α+ cells within the group handled with 10 mg/kg HCQ was important within the first section (p worth < 0.05).
Contemplating that the 100 mg/kg HCQ group had the best degree of PDGFR-α in addition to the best degree of myelin restore in LFB staining, it might be inferred that it was the best dose in inducing proliferation and migration of OPCs.
| REN ELISA Kit| Rat Renin ELISA Kit | |||
| EF017245 | |||
| Pir ELISA Kit| Rat Pirin ELISA Kit | |||
| EF019186 | |||
| Kl ELISA Kit| Rat Klotho ELISA Kit | |||
| EF017474 | |||
Bee Venom-Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Mannequin of A number of Sclerosis
A number of sclerosis is a power demyelinating illness with a useful disturbance within the immune system and axonal damages. It was proven that Apamin as a blood-brain barrier shuttle acts as a Ca2+ activated Ok+ channels (SK channels) blocker.
On this examine, the results of Apamin on oligodendrocyte differentiation markers had been evaluated on an induced mannequin of MS. Briefly, C57BL/6 male mice (22 ± 5 g) besides the management group had been fed with 0.2% (w/w) cuprizone pellets for six weeks.
After cuprizone withdrawal, mice had been divided randomly into six teams. Apamin (100 µg/kg/BW) was administered intraperitoneally as a co-treatment throughout section I (demyelination) or post-treatment section II (remyelination) twice every week.
Mice had been anesthetized, perfused with phosphate-buffered saline, then fastened brains had been coronally sectioned and the modifications in oligodendrocytes markers reminiscent of Olig2, PDGFR-α, and BrdU incorporation had been assessed by immunohistochemistry assay.
Apamin administration elevated Olig2+ cells in section I as in comparison with the management group (p < 0.0001). Additionally, a lowering pattern in PDGFRa+ cells noticed after cuprizone withdrawal (p < 0.001). 5-Bromo-2′-deoxyuridine (BrdU) incorporation check was confirmed stimulation of oligodendrocyte progenitor cell proliferation in section I within the Apamin uncovered group (p < 0.0001), particularly on the subventricular zone.
This examine highlights the potential therapeutic results of Apamin as a bee venom-derived peptide on oligodendrocyte precursor proliferation and elevation in myelin content material in an oxidative induced a number of sclerosis mannequin because of cuprizone publicity.
| REN ELISA Kit| Rat Renin ELISA Kit | |
| EF017245 | Lifescience Market |
| Pir ELISA Kit| Rat Pirin ELISA Kit | |
| EF019186 | Lifescience Market |
| Kl ELISA Kit| Rat Klotho ELISA Kit | |
| EF017474 | Lifescience Market |
| LN ELISA Kit| Rat Laminin ELISA Kit | |
| EF017041 | Lifescience Market |
| Lep ELISA Kit| Rat Leptin ELISA Kit | |
| EF017074 | Lifescience Market |
Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice
Oligodendrocytes, the myelinating cells of the central nervous system, orchestrate a number of key mobile capabilities within the mind and spinal twine, together with axon insulation, power switch to neurons, and, ultimately, modulation of immune responses.
There’s rising curiosity for acquiring dependable markers that may particularly label oligodendroglia and their progeny. In lots of research, anti-CC1 antibodies, presumably recognizing the protein adenomatous polyposis coli (APC), are used to label mature, myelinating oligodendrocytes.
Nevertheless, it has been mentioned whether or not anti-CC1 antibodies might acknowledge as effectively, underneath pathological situations, different cell populations, notably astrocytes. On this examine, we used transgenic mice by which astrocytes are labeled by the improved inexperienced fluorescent protein (eGFP) underneath the management of the human glial fibrillary acidic protein (GFAP) promoter.
By detailed co-localization research we had been capable of reveal that a important proportion of eGFP-expressing cells co-express markers of the oligodendrocyte lineage, such because the transcription issue Oligodendrocyte Transcription Issue 2 (OLIG2); the NG2 proteoglycan, also referred to as chrondroitin sulfate proteoglycan 4 (CSPG4); or APC.
The present discovering that the GFAP promoter drives transgene expression in cells of the oligodendrocyte lineage needs to be thought of when deciphering outcomes from co-localization research.
| REN ELISA Kit| Rat Renin ELISA Kit | |||
| Lifescience Market | |||
| Pir ELISA Kit| Rat Pirin ELISA Kit | |||
| Lifescience Market | |||
| Kl ELISA Kit| Rat Klotho ELISA Kit | |||
| Lifescience Market | |||
Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells utilizing triiodothyronine as a inducer with expression of platelet-derived development issue α as a maturity marker.
The current examine investigated the useful maturity of oligodendrocyte derived from rat bone marrow stromal cells (BMSC).
The BMSC had been remoted from feminine Sprague-Dawley rats and evaluated for various markers, reminiscent of fibronectin, CD106, CD90, Oct-Four and CD45.
Transdifferentiation of OLC from BMSC was obtained by exposing the BMSC to DMSO and 1 µM all-trans-retinoic acid in the course of the pre-induction stage after which induced by heregulin (HRG), platelet-derived development issue AA (PDGFR-alpha), fibroblast development issue and T3.
The neuroprogenitor cells (NPC) had been evaluated for nestin, neurofilament 68, neurofilament 160 and glial fibrillary acidic protein gene expression utilizing immunocytochemistry. The OLC had been assessed by immunocytochemistry for O4, oligo2, O1 and MBP marker and gene expression of PDGFR-alpha was examined by RT-PCR.
Our outcomes confirmed that the fibronectin, CD106, CD90, CD45 and Oct-Four had been expressed after the fourth passage. Additionally, the yield of OLC differentiation was about 71% when utilizing the O1, O4 and oligo2 markers.
Likewise, the expression of PDGFR-alpha in pre-oligodendrocytes was observed, whereas MBP expression was detected in oligodendrocyte after 6 days of the induction.
The conclusion of the examine confirmed that BMSC will be induced to transdifferentiate into mature OLC.
| REN ELISA Kit| Rat Renin ELISA Kit | |||
| EF017245 | |||
| Pir ELISA Kit| Rat Pirin ELISA Kit | |||
| EF019186 | |||
| Kl ELISA Kit| Rat Klotho ELISA Kit | |||
| EF017474 | |||
Results of hexachlorophene on myelin marker enzymes in rat oligodendrocytes.
The antibacterial substance hexachlorophene (HCP) can have an effect on myelin formation or integrity resulting in intramyelinic oedema and vacuolation within the central nervous system by way of an unknown mechanism. These research had been performed to analyze the direct, dose-dependent results of HCP on myelin membrane markers in cultured oligodendrocytes (OLG) remoted from 4-7-day-old rat pups and cultured in vitro for as much as 5 wk.
2-wk-old OLG cultures had been uncovered to 0, 0.24 or 0.74 mum HCP for 48 hr. At 48 hr and once more at 5, 12 and 19 days after the top of dosing the myelin markers galactosylceramide (GalC), myelin fundamental protein (MBP), and a couple of’,3′-cyclic nucleotide 3′-phosphohydrolase (CNPase) had been quantified by ELISA or biochemical strategies.
DNA was measured to estimate whole cell mass and astrocyte contamination was decided by an ELISA process utilizing anti-glial fibrillary acidic protein (GFAP) as the first antibody. Due to the usage of a selective tradition medium, astrocyte contamination was initially low and continued to lower from wk 2 to Four as decided by GFAP binding.
CNPase, GalC and MBP ranges had been related in management and low-dose (0.24 mum HCP) cultures with a common improve in MBP and CNPase over time. Cultures uncovered to 0.74 mum HCP confirmed a decline in GalC proportional to decreased DNA content material with time, however ranges of MBP and CNPase elevated after dosing and had been at all times better than the corresponding ranges in management or low-dose cultures.
Myelin Oligodendrocyte Glycoprotein |
|||
| 7-05615 | CHI Scientific | 25mg | Ask for price |
Myelin Oligodendrocyte Glycoprotein |
|||
| 7-05616 | CHI Scientific | 100mg | Ask for price |
Myelin oligodendrocyte glycoprotein |
|||
| E8ET1705-16 | EnoGene | 100ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
Myelin Oligodendrocyte GlycoProtein |
|||
| 22060604-1 | Bio-WORLD | 5 mg | EUR 182.1 |
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF647 conjugate, 0.1mg/mL |
|||
| BNC473001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF647 conjugate, 0.1mg/mL |
|||
| BNC473001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF568 conjugate, 0.1mg/mL |
|||
| BNC683001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF568 conjugate, 0.1mg/mL |
|||
| BNC683001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF594 conjugate, 0.1mg/mL |
|||
| BNC943001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF594 conjugate, 0.1mg/mL |
|||
| BNC943001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF405S conjugate, 0.1mg/mL |
|||
| BNC043001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF405S conjugate, 0.1mg/mL |
|||
| BNC043001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF640R conjugate, 0.1mg/mL |
|||
| BNC403001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF640R conjugate, 0.1mg/mL |
|||
| BNC403001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF488A conjugate, 0.1mg/mL |
|||
| BNC883001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), CF488A conjugate, 0.1mg/mL |
|||
| BNC883001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), Biotin conjugate, 0.1mg/mL |
|||
| BNCB3001-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Transferrin (Early Marker of Oligodendrocytes)(TF/3001), Biotin conjugate, 0.1mg/mL |
|||
| BNCB3001-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Myelin Oligodendrocyte Glycoprotein antibody |
|||
| 10R-7783 | Fitzgerald | 500 ug | EUR 664.8 |
|
Description: Mouse monoclonal Myelin Oligodendrocyte Glycoprotein antibody |
|||
Myelin oligodendrocyte glycoprotein Antibody |
|||
| 49609-100ul | SAB | 100ul | EUR 399.6 |
Myelin oligodendrocyte glycoprotein Antibody |
|||
| 49609-50ul | SAB | 50ul | EUR 286.8 |
Myelin oligodendrocyte glycoprotein Rabbit mAb |
|||
| A3992 | Abclonal | 20 μL | EUR 18 |
Myelin oligodendrocyte glycoprotein Rabbit mAb |
|||
| A3992-100ul | Abclonal | 100 ul | EUR 492 |
Myelin oligodendrocyte glycoprotein Rabbit mAb |
|||
| A3992-200ul | Abclonal | 200 ul | EUR 685.2 |
Myelin oligodendrocyte glycoprotein Rabbit mAb |
|||
| A3992-20ul | Abclonal | 20 ul | EUR 265.2 |
Myelin oligodendrocyte glycoprotein Rabbit mAb |
|||
| A3992-50ul | Abclonal | 50 ul | EUR 344.4 |
Myelin oligodendrocyte glycoprotein Rabbit pAb |
|||
| E2382054 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Myelin Oligodendrocyte Glycoprotein (35-55) (human) |
|||
| H-5912.0500 | Bachem | 0.5mg | EUR 297.6 |
|
Description: Sum Formula: C120H179N35O28S; CAS# [163158-19-8] net |
|||
Myelin Oligodendrocyte Glycoprotein (35-55) (human) |
|||
| H-5912.1000 | Bachem | 1.0mg | EUR 471.6 |
|
Description: Sum Formula: C120H179N35O28S; CAS# [163158-19-8] net |
|||
Myelin Oligodendrocyte Glycoprotein (MOG) Protein |
|||
| 20-abx260391 | Abbexa |
|
|
Human Oligodendrocyte transcription factor 2 (OLIG2) |
|||
| 1-CSB-EP623814HU | Cusabio |
|
|
|
Description: Recombinant Human Oligodendrocyte transcription factor 2(OLIG2) expressed in E.coli |
|||
Human Oligodendrocyte transcription factor 1 (OLIG1) |
|||
| 1-CSB-YP016328HU | Cusabio |
|
|
|
Description: Recombinant Human Oligodendrocyte transcription factor 1(OLIG1),partial expressed in Yeast |
|||
Human Oligodendrocyte transcription factor 2 (OLIG2) |
|||
| 1-CSB-MP623814HU | Cusabio |
|
|
|
Description: Recombinant Human Oligodendrocyte transcription factor 2 (OLIG2) expressed in Mammalian cell |
|||
These research counsel a direct, dose-related poisonous impact of HCP accompanied by a stimulation of MBP and CNPase however not of GalC manufacturing within the membranes of the recovering OLG following removing of HCP.
| REN ELISA Kit| Rat Renin ELISA Kit | |||
| Lifescience Market | |||
| Pir ELISA Kit| Rat Pirin ELISA Kit | |||
| Lifescience Market | |||
| Kl ELISA Kit| Rat Klotho ELISA Kit | |||
| Lifescience Market | |||
| LN ELISA Kit| Rat Laminin ELISA Kit | |||
| Lifescience Market | |||
| Lep ELISA Kit| Rat Leptin ELISA Kit | |||
| Lifescience Market | |||
